IP Library Granted Patent US 8,048,861
Granted Patent B2
US 8,048,861 · App. 12/757,153 · Granted Nov 1, 2011

Pesticidal formulations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,048,861
App. No.
12/757,153
Granted
Nov 1, 2011
Kind
B2
Abstract

The present invention relates to an active composition for controlling or eradicating Phthiraptera, Siphonaptera and Acarina Pests, typically in domestic animals, comprising a synergistic combination of at least one A83543 compound and at least one macrocyclic lactone. The invention also relates to the use of the active composition in pesticidal formulations, the formulations themselves and to the various applications of those formulations as pesticides, specifically in controlling all species of Phthiraptera, Siphonaptera and Acarina pests, typically in domestic animals. Such applications include the control of such external Phthiraptera, Siphonaptera and Acarina pests in domestic animals including but not limited to sheep, cattle, poultry, pigs, goats, camelids, horses, dogs and cats.

Claims (28)

1. A method of controlling a pest in a domestic animal comprising administering a systemically active oral composition comprising a combination of spinosad, or a salt thereof, and milbemycin oxime in a 10:1 to 100:1 weight/weight ratio, and at least one veterinarily acceptable carrier, diluent, or excipient, to said domestic animal, said domestic animal selected from sheep, cattle, poultry, pigs, goats, camellids, horses, and cats.

2. The method of claim 1 wherein said spinosad, or a salt thereof, and milbemycin oxime are from 0.1% -40% by weight of the composition.

3. The method of claim 2 wherein said at least one veterinarily acceptable carrier, diluent, or excipient is 60-99% by weight of the composition.

4. The method of claim 1 wherein said composition is in the form of a tablet, capsule, bolus, solution, suspension, or elixir.

5. The method of claim 1 wherein said composition comprises spinosad.

6. The method of claim 1 wherein said composition is in the form of a tablet, and said at least one veterinarily acceptable carrier, diluent, or excipient is a flavoring agent.

7. A method of controlling a pest in a domestic animal comprising administering a systemically active oral composition consisting essentially of a combination of spinosad, or a salt thereof, and milbemycin oxime in a 10:1 to 100:1 weight/weight ratio, and at least one veterinarily acceptable carrier, diluent, or excipient, to said domestic animal, said domestic animal selected from sheep, cattle, poultry, pigs, goats, camellids, horses, and cats.

8. The method of claim 7 wherein said spinosad, or a salt thereof, and milbemycin oxime are from 0.1% -40% by weight of the composition.

9. The method of claim 8 wherein said at least one veterinarily acceptable carrier, diluent, or excipient is 60-99% by weight of the composition.

10. The method of claim 7 wherein said composition is in the form of a tablet, capsule, bolus, solution, suspension, or elixir.

11. The method of claim 10 wherein said composition comprises spinosad.

12. The method of claim 11 wherein said composition is in the form of a tablet and said at least one veterinarily acceptable carrier, diluent, or excipient is a flavoring agent.

13. A systemically active oral composition comprising a combination of spinosad, or a salt thereof, and milbemycin oxime in a 10:1 to 100:1 weight/weight ratio, and at least one veterinarily acceptable carrier, diluent, or excipient.

14. The composition of claim 13 wherein said spinosad, or a salt thereof, and milbemycin oxime are from 0.1% -40% by weight of the composition.

15. The composition of claim 14 wherein said at least one veterinarily acceptable carrier, diluent, or excipient is 60-99% by weight of the composition.

16. The composition of claim 13 wherein said composition is in the form of a tablet, capsule, bolus, solution, suspension, or elixir.

17. The composition of claim 13 wherein said composition comprises spinosad.

18. The composition of claim 13 wherein said composition is in the form of a tablet, and said at least one veterinarily acceptable carrier, diluent, or excipient is a flavoring agent.

19. A method of controlling a pest in a domestic animal comprising administering the composition of claim 13 to said domestic animal.

20. The method of claim 19 where said domestic animal is a dog.

21. A systemically active oral composition consisting essentially of a combination of spinosad, or a salt thereof, and milbemycin oxime in a 10:1 to 100:1 weight/weight ratio, and at least one veterinarily acceptable carrier, diluent, or excipient.

22. The composition of claim 21 wherein said spinosad, or a salt thereof, and milbemycin oxime are from 0.1% -40% by weight of the composition.

23. The composition of claim 22 wherein said at least one veterinarily acceptable carrier, diluent, or excipient is 60-99% by weight of the composition.

24. The composition of claim 21 wherein said composition is in the form of a tablet, capsule, bolus, solution, suspension, or elixir.

25. The composition of claim 24 wherein said composition comprises spinosad.

26. The composition of claim 25 wherein said composition is in the form of a tablet and said at least one veterinarily acceptable carrier, diluent, or excipient is a flavoring agent.

27. A method of controlling a pest in a domestic animal comprising administering the composition of claim 26 to said domestic animal.

28. The method of claim 27 where said domestic animal is a dog.

Assignments (3)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON AUGUST 3, 2020, AT REEL/FRAME 053388/0967 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0021 →
SECURITY INTEREST Recorded Aug 3, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 053388/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: ELI LILLY AND COMPANY
To: ELANCO US INC.
Reel/Frame 044696/0140 →